Launch of a pioneering clinical trial to validate the efficacy of immunotherapy in 29 types of tumour

by Fundació Clínic per a la Recerca Biomèdica

​The ACROPOLI clinical trial is being launched. It is a pioneering, nationwide research study that aims to assess the efficacy of immunotherapy in 29 different types of cancer simultaneously.

Read more

The future of immunotherapy at the Optimizing Immunotherapy Congress

by IMIM - Institut Hospital del Mar d'Investigacions Mèdiques

​The benchmark meeting in the field of immunotherapy cancer treatment was held once again, on April 9, in a hybrid format. This year, the presentations focused on the research and development of thi...

Read more

A study in Nature concludes that immunotherapy is less efficacious in nonviral liver cancer

by Fundació Clínic per a la Recerca Biomèdica

An article published in the journal Nature suggests that immunotherapy is effective in patients with HCC of viral origin but does not increase survival of patients with HCC caused by alcohol abuse or ...

Read more

Predicting how brain cancer responds to immunotherapy non-invasively

by Centre for Genomic Regulation

The analysis of immune system cells in the cerebrospinal fluid can characterise and identify the types of cerebral metastasis that could respond to immunotherapy treatments.

Read more

Spanish scientists identify a mechanism through which dendritic cells improve their antiviral and immune-activation abilities

by Centro Nacional de Investigaciones Cardiovasculares - CNIC

Researchers at the CNIC have discovered that dendritic cells, which initiate specific immune responses, can reprogram their genes to improve their immune response

Read more

CNIO research team finds how melanoma deceives the immune system, increasing resistance to immunotherapy

by CNIO - Centro Nacional de Investigaciones Oncológicas

The sophisticated human immune system has evolved to become an effective protection system against a great number of diseases, cancer being one of them. The immune system recognises and destroys cance...

Read more

ID-Hub media spoke with José Javier García, Pivotal´s VP, Data management and Biostatistics, about adaptive study design and the potential for convalescent plasma therapy in COVID-19 patients

by Pivotal

In this interview we speak to José Javier García, Vice President of Data Management and Biostatistics at Pivotal (Madrid, Spain), about his company’s involvement in a large-scale clinical trial te...

Read more

An international research identifies a biomarker predicting prognosis for immunotherapy-treated patients with advanced cancer

by CIMA - Centro de Investigación Médica Aplicada

Researchers from Cima and the Clínica Universidad de Navarra show that high IL-8 levels are linked to worse patient response to the treatment

Read more

International scientists point to immunotherapy as a new approach for treating diseases related to ageing

by IRB Barcelona - Instituto de Investigación Biomédica

When you hear the word ‘immunotherapy’, the first thing that comes to mind is that it is a highly effective treatment for cancer. But could it also be the solution or hope for other conditions?

Read more

Predicting the response of HIV-infected individuals to checkpoint inhibitor immunotherapy

by UPF - Universitat Pompeu Fabra

Scientists led by Andreas Meyerhans and Gennady Bocharov have designed a mathematical model to predict the response of HIV-infected individuals to a type of cancer immunotherapy.

Read more

Scientists build machine learning-based algorithm to predict which cancer patients benefit from immunotherapy

by IRB Barcelona - Instituto de Investigación Biomédica

Using machine learning, researchers have built a tool that detects genetic mutations that trigger the immune system, helping identify which cancer patients are more likely to benefit from immunotherap...

Read more
Subscribe to Directory
Write an Article

Recent News

Tuneable reverse photochromes in the sol...

A new technique allows the design of solid materia...

La Unidad de Chequeos de la Clínica sup...

El estudio realizado sobre una muestra significati...


Interview with Dámaso Molero, general m...

by 3P Biopharmaceuticals

Dámaso Molero: “There are great opportunities in Latin America for ...

La impronta inmunológica condiciona la ...

by Hospital Universitari de Bellvitge

Un estudio del Hospital de Bellvitge, el IDIBELL y la Icahn School of ...

Photos Stream